Cantor Fitzgerald’s ResMed RMD Stock Holding History

Cantor Fitzgerald’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,000	Closed	-$219K	–	637
2023 Q1	$219K	Buy	+1,000	New	+$217K	﹤0.01%	530

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cantor Fitzgerald's RMD Position: Q2 2023 in Review

Cantor Fitzgerald sold out of ResMed (RMD) in Q2 2023, closing a stake of 1,000 shares — an estimated $219K sold.

Cantor Fitzgerald first reported a position in RMD in Q1 2023 and held it in 1 quarter. The position peaked at $219K in Q1 2023. 731 funds tracked by Wall St. Rank hold RMD as of Q2 2023.

Cantor Fitzgerald reported no remaining ResMed position as of Q2 2023 after selling out during the quarter.
Cantor Fitzgerald sold 1,000 ResMed shares in Q2 2023, an estimated $219K.
Cantor Fitzgerald first reported a position in ResMed in Q1 2023 and held it in 1 quarter.
Cantor Fitzgerald's ResMed position peaked at $219K in Q1 2023.
731 funds tracked by Wall St. Rank held ResMed as of Q2 2023.

Based on Cantor Fitzgerald's 13F filing for Q2 2023, filed 14 Aug 2023.